Center for Biological Diversity
EPANonrulemakingEPA-HQ-OPP-2021-0575

National Level Threatened and Endangered Species Biological Evaluations for Clothianidin, Imidacloprid and Thiamethoxam

RIN
Last modified
Sep 7, 2022
Comment window
closed 1737d ago
Center for Biological Diversity filings
6

Activity

Center for Biological Diversity filed 6 comments on this docket between Nov 16, 2021 and Nov 23, 2021. 41 other organizations filed here. The comment window closed 1737d ago.

What Center for Biological Diversity filed (6)

Nov 23, 2021· Mass Comment Campaign Sponsored by Center for Biological Diversity (21,857 web comments)· EPA-HQ-OPP-2021-0575-0470

Filed on regulations.gov — full text not in the inline record.

Nov 16, 2021· Comment submitted by Center for Biological Diversity (Part 1 of 5)· EPA-HQ-OPP-2021-0575-0460

Please find attached comments and additional materials by the Center for Biological Diversity. More additional materials will be submitted in subsequent submissions

Nov 16, 2021· Comment submitted by Center for Biological Diversity (Part 4 of 5)· EPA-HQ-OPP-2021-0575-0463

Filed on regulations.gov — full text not in the inline record.

Nov 16, 2021· Comment submitted by Center for Biological Diversity (Part 2 of 5)· EPA-HQ-OPP-2021-0575-0461

Filed on regulations.gov — full text not in the inline record.

Nov 16, 2021· Comment submitted by Center for Biological Diversity (Part 5 of 5)· EPA-HQ-OPP-2021-0575-0464

Filed on regulations.gov — full text not in the inline record.

Nov 16, 2021· Comment submitted by Center for Biological Diversity (Part 3 of 5)· EPA-HQ-OPP-2021-0575-0462

Filed on regulations.gov — full text not in the inline record.

Abstract

EPA is seeking comment on draft Endangered Species Act (ESA) biological evaluations relative to the potential effects of clothianidin, imidacloprid and thiamethoxam on threatened or endangered (listed) species and their designated critical habitats.

View on regulations.gov →